ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 84 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,163 | +11.1% | 154,409 | +7.8% | 0.00% | 0.0% |
Q2 2023 | $2,846 | +3.1% | 143,217 | -11.1% | 0.00% | +100.0% |
Q1 2023 | $2,761 | -21.7% | 161,142 | -10.6% | 0.00% | -50.0% |
Q4 2022 | $3,528 | -99.9% | 180,225 | +20.3% | 0.00% | -33.3% |
Q3 2022 | $2,392,000 | +48.1% | 149,833 | +27.7% | 0.00% | +200.0% |
Q2 2022 | $1,615,000 | -79.9% | 117,353 | -76.8% | 0.00% | -83.3% |
Q1 2022 | $8,018,000 | -58.2% | 505,544 | -42.4% | 0.01% | +50.0% |
Q4 2021 | $19,176,000 | +220.2% | 878,368 | +338.3% | 0.00% | +33.3% |
Q3 2021 | $5,989,000 | +199.3% | 200,396 | +343.6% | 0.00% | +200.0% |
Q2 2021 | $2,001,000 | +11.0% | 45,180 | +11.2% | 0.00% | 0.0% |
Q1 2021 | $1,802,000 | -49.8% | 40,647 | -37.9% | 0.00% | -50.0% |
Q4 2020 | $3,591,000 | +60.0% | 65,487 | -33.3% | 0.00% | +100.0% |
Q3 2020 | $2,245,000 | +69.9% | 98,209 | +55.7% | 0.00% | 0.0% |
Q2 2020 | $1,321,000 | -61.8% | 63,087 | -74.5% | 0.00% | -66.7% |
Q1 2020 | $3,456,000 | +358.4% | 247,755 | +649.1% | 0.00% | – |
Q4 2019 | $754,000 | +262.5% | 33,073 | +85.0% | 0.00% | – |
Q3 2019 | $208,000 | -36.8% | 17,878 | -18.5% | 0.00% | – |
Q2 2019 | $329,000 | -12.5% | 21,938 | +2.5% | 0.00% | – |
Q1 2019 | $376,000 | -9.8% | 21,412 | +26.5% | 0.00% | – |
Q3 2018 | $417,000 | +160.6% | 16,931 | +107.6% | 0.00% | – |
Q2 2018 | $160,000 | -76.4% | 8,156 | -77.4% | 0.00% | -100.0% |
Q1 2018 | $677,000 | – | 36,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |